BZPEERReading, trust and collaboration for research
Menu

Discover

GraphFollow connections around a paper, topic or saved view.

Workspaces

HomePick up where your research flow left off.InboxHandle requests, replies and notifications from one place.CollectionsCurate reading lists, evidence sets and shareable dossiers.ResearchSee your private provenance graph, trail and imports.CollaborationMove from discovery into focused discussion rooms.PublishDraft, preview and publish full-text research articles.

Network

ExpertsFind specialists worth following or asking for help.CommunitiesJoin research circles organized around shared work.PartnersSee external organizations active around the same topics.

Opportunities

ListingsBrowse roles, calls and collaborations with clearer fit signals.

Account

Log inReturn to your reading and collaboration workspace.Create accountStart saving work, following people and joining teams.
Log inCreate account

Researcher profile

Alejandro Anderson

Alejandro Anderson contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate
Populations and Evolutionmath.DSmath.OC

Trust snapshot

Quick read

Trust 17 - UnverifiedVerification L1Unclaimed author
4works
0followers
3topics
4close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

4 published item(s)

preprint2025arXiv

Failure and Success in Single-Drug Control of Antimicrobial Resistance

We propose a mathematical model of Antimicrobial Resistance in the host to predict the failure of two antagonists of bacterial growth: the immune response and a single-antibiotic therapy. After characterising the initial bacterial load that cannot be cleared by the immune system alone, we define the success set of initial conditions for which an infection-free equilibrium can be reached by a viable single-antibiotic therapy, and we provide a rigorously defined inner approximation of the set. For initial conditions within the success set, we propose an optimal control framework to design single-drug therapies.

0 citations0 reviewsNo code linkedOpen access
preprint2020arXiv

Characterization of SARS-CoV-2 Dynamics in the Host

While many epidemiological models have being proposed to understand and handle COVID-19, too little has been invested to understand how the virus replicates in the human body and potential antiviral can be used to control the replication cycle. In this work, using a control theoretical approach, validated mathematical models of SARS-CoV-2 in humans are properly characterized. A complete analysis of the main dynamic characteristic is developed based on the reproduction number. The equilibrium regions of the system are fully characterized, and the stability of such a regions, formally established. Mathematical analysis highlights critical conditions to decrease monotonically SARS-CoV-2 in the host, such conditions are relevant to tailor future antiviral treatments. Simulation results show the potential benefits of the aforementioned system characterization.

0 citations0 reviewsNo code linkedOpen access
preprint2020arXiv

Discrete-time MPC for switched systems with applications to biomedical problems

Switched systems in which the manipulated control action is the time-depending switching signal describe many engineering problems, mainly related to biomedical applications. In such a context, to control the system means to select an autonomous system - at each time step - among a given finite family. Even when this selection can be done by solving a Dynamic Programming (DP) problem, such a solution is often difficult to apply, and state/control constraints cannot be explicitly considered. In this work a new set-based Model Predictive Control (MPC) strategy is proposed to handle switched systems in a tractable form. The optimization problem at the core of the MPC formulation consists in an easy-to-solve mixed-integer optimization problem, whose solution is applied in a receding horizon way. Two biomedical applications are simulated to test the controller: (i) the drug schedule to attenuate the effect of viral mutation and drugs resistance on the viral load, and (ii) the drug schedule for Triple Negative breast cancer treatment. The numerical results suggest that the proposed strategy outperform the schedule for available treatments.

0 citations0 reviewsNo code linkedOpen access
preprint2020arXiv

Dynamical Characterization of Antiviral Effects in COVID-19

Mathematical models describing SARS-CoV-2 dynamics and the corresponding immune responses in patients with COVID-19 can be critical to evaluate possible clinical outcomes of antiviral treatments. In this work, based on the concept of virus spreadability in the host, antiviral effectiveness thresholds are determined to establish whether or not a treatment will be able to clear the infection. In addition, the virus dynamic in the host -- including the time-to-peak and the final monotonically decreasing behavior -- is chracterized as a function of the treatment initial time. Simulation results, based on nine real patient data, show the potential clinical benefits of a treatment classification according to patient critical parameters. This study is aimed at paving the way for the different antivirals being developed to tackle SARS-CoV-2.

0 citations0 reviewsNo code linkedOpen access